A Study of Chemotherapy and Certolizumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to explore adding the study drug certolizumab to standard
chemotherapy as it may reduce the inflammation caused by the cancer and make the chemotherapy
more effective in shrinking the cancer. This study will examine whether adding certolizumab
to the usual treatment approach is better than, the same as, or worse than the usual approach
alone.